Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice
- 31 July 2006
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 45 (1), 20-27
- https://doi.org/10.1016/j.jhep.2006.01.039
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver diseaseHepatology, 2004
- Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusionHepatology, 2004
- Dual role of tumor necrosis factor-α in hepatic ischemia-reperfusion injury: Studies in tumor necrosis factor-α gene knockout miceHepatology, 2004
- In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in ratsGastroenterology, 2003
- Low-dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: Implications for preconditioningHepatology, 2003
- Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: A TNF-α/IL-6-dependent mechanismHepatology, 2002
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000
- Liver regenerationJournal of Hepatology, 2000
- Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodentHepatology, 1997
- Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.Journal of Clinical Investigation, 1990